Biologist pushes back on 'automate all labs': only ~20% of assays make sense

anshulkundaje · x · 2026-10-14

Responding to claims that all labs must be automated, biologist Haley Salis argues only 20% of biotech assays are high-volume and high-demand enough to justify automation. The remaining 80% are low-demand, plate-free, and rely on specialized equipment. Stanford professor Anshul Kundaje amplified the take.

Original post →

More from AGI Musings

AGI Musings channel →